New trend in deadly cases of prostate cancer - WTNH.com
New trend in deadly cases of prostate cancer WTNH.com
Prostate Cancer News
Dad, 68, Dies of Prostate Cancer After Doctors Ignored His Symptoms for 9 Years Before Diagnosis - People.com
Dad, 68, Dies of Prostate Cancer After Doctors Ignored His Symptoms for 9 Years Before Diagnosis People.com
New blood test detects aggressive prostate cancer more accurately than PSA, study finds - LiveNOW from FOX
New blood test detects aggressive prostate cancer more accurately than PSA, study finds LiveNOW from FOX
Low grip strength should not be used as an independent predictor of prostate cancer in older men - Medical Xpress
Low grip strength should not be used as an independent predictor of prostate cancer in older men Medical Xpress
CAN-2409 Plus Radiotherapy for Localized Prostate Cancer in a Phase III Trial, Journal Club - Rashid Sayyid & Zachary Klaassen - UroToday
CAN-2409 Plus Radiotherapy for Localized Prostate Cancer in a Phase III Trial, Journal Club - Rashid Sayyid & Zachary Klaassen UroToday
Patient selection for perioperative treatment in high-risk localized prostate cancer - Urology Times
Patient selection for perioperative treatment in high-risk localized prostate cancer Urology Times
A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters - Pfizer
A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters Pfizer
Is frequent ejaculation really the secret to lowering prostate cancer risk? - Futura, le média qui explore le monde
Is frequent ejaculation really the secret to lowering prostate cancer risk? Futura, le média qui explore le monde
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings - Fox News
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings Fox News
J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study - Reuters
J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study Reuters
Creativity Awards - Prostate Cancer Foundation (PCF)
Creativity Awards Prostate Cancer Foundation (PCF)
Availability, Tolerability, and Drug Interactions Drive ARPI Selection in mHSPC - Targeted Oncology
Availability, Tolerability, and Drug Interactions Drive ARPI Selection in mHSPC Targeted Oncology
MDxHealth Study Backs Prostate Cancer Test - Orange County Business Journal
MDxHealth Study Backs Prostate Cancer Test Orange County Business Journal
Doctors urge men to prioritize preventative care during Men’s Health Month - Live 5 News
Doctors urge men to prioritize preventative care during Men’s Health Month Live 5 News
Generic Enzalutamide Tablets Granted Tentative FDA Approval for Prostate Cancer - OncLive
Generic Enzalutamide Tablets Granted Tentative FDA Approval for Prostate Cancer OncLive
Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond - Novartis
Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond Novartis
New Prostate Cancer Treatments Aim to Reduce Deaths and Avoid Side Effects - Memorial Sloan Kettering Cancer Center
New Prostate Cancer Treatments Aim to Reduce Deaths and Avoid Side Effects Memorial Sloan Kettering Cancer Center
Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer - CancerNetwork
Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer CancerNetwork
Cobb Library and Winship Partnership Sets New Record for Community Prostate Cancer Screenings - Cobb County (.gov)
Cobb Library and Winship Partnership Sets New Record for Community Prostate Cancer Screenings Cobb County (.gov)
Prostate Cancer Statistics 2026 - Cancer Therapy Advisor
Prostate Cancer Statistics 2026 Cancer Therapy Advisor
Personalizing ARPI Selection in mCSPC - Urology Times
Personalizing ARPI Selection in mCSPC Urology Times
CAPItello-281 Phase III Results and the Role of AKT Inhibition in mHSPC, Journal Club - Zachary Klaassen & Rashid Sayyid - UroToday
CAPItello-281 Phase III Results and the Role of AKT Inhibition in mHSPC, Journal Club - Zachary Klaassen & Rashid Sayyid UroToday
Sanoj Punnen, MD, on balancing ADT efficacy with cardiovascular safety - Urology Times
Sanoj Punnen, MD, on balancing ADT efficacy with cardiovascular safety Urology Times
Evolving Systemic Therapies in mCSPC - Urology Times
Evolving Systemic Therapies in mCSPC Urology Times
When celebrities talk about their prostate cancer, here’s what happens next - The Conversation
When celebrities talk about their prostate cancer, here’s what happens next The Conversation
Dad, 68, Dies of Prostate Cancer After Doctors Ignored His Symptoms for 9 Years Before Diagnosis - AOL.com
Dad, 68, Dies of Prostate Cancer After Doctors Ignored His Symptoms for 9 Years Before Diagnosis AOL.com
Experimental treatment kills prostate tumor cells while reawakening antitumor immunity - Cornell Chronicle
Experimental treatment kills prostate tumor cells while reawakening antitumor immunity Cornell Chronicle
Family angry at nine-year cancer diagnosis delay - BBC
Family angry at nine-year cancer diagnosis delay BBC
A cheaper scan may change how doctors detect prostate cancer - Earth.com
A cheaper scan may change how doctors detect prostate cancer Earth.com
INTERVIEW: Prostate cancer affects 1 in 8 men — here’s how to catch it early - KPTV
INTERVIEW: Prostate cancer affects 1 in 8 men — here’s how to catch it early KPTV
MLB, clubs to raise prostate cancer awareness on Father's Day - MLB.com
MLB, clubs to raise prostate cancer awareness on Father's Day MLB.com
Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer - U.S. News & World Report
Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer U.S. News & World Report
INTERVIEW: Prostate cancer affects 1 in 8 men — here’s how to catch it early - WECT
INTERVIEW: Prostate cancer affects 1 in 8 men — here’s how to catch it early WECT
10 Must-Read Posts In GU Oncology This Week - Oncodaily
10 Must-Read Posts In GU Oncology This Week Oncodaily
Very Few Men Discuss Prostate Cancer Screening With Their Doctor - U.S. News & World Report
Very Few Men Discuss Prostate Cancer Screening With Their Doctor U.S. News & World Report
Emory’s Winship Prostate Cancer Screening Bus - Free Screening - Cobb County (.gov)
Emory’s Winship Prostate Cancer Screening Bus - Free Screening Cobb County (.gov)
Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer - AstraZeneca
Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer AstraZeneca
Five Under 5: Top Oncology Videos for the Week of 6/21 - OncLive
Five Under 5: Top Oncology Videos for the Week of 6/21 OncLive
Prostate Biopsy Devices Market To Reach New Heights by 2035 Amid Surge in Precision Biopsy Adoption and Recurring Consumables Demand - News and Statistics - IndexBox
Prostate Biopsy Devices Market To Reach New Heights by 2035 Amid Surge in Precision Biopsy Adoption and Recurring Consumables Demand - News and Statistics IndexBox
U.S. Cancer Statistics Prostate Cancer Stat Bite - Centers for Disease Control and Prevention | CDC (.gov)
U.S. Cancer Statistics Prostate Cancer Stat Bite Centers for Disease Control and Prevention | CDC (.gov)